Form D — EnZeta Immunotherapies, Inc.
0001994145-26-000001 · filed 2026-03-06
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,370,000
- Total sold
- $840,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- EnZeta Immunotherapies, Inc.
- CIK
- 1994145
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 122 SEVILLA AVE # 919
CORAL GABLES, FL 33134 - Phone
- 9173644613
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Paul Kelly · Executive OfficerCoral Gables, FL Find on LinkedIn ↗
-
Sergio Traversa · DirectorMiami, FL Find on LinkedIn ↗
View original on SEC EDGAR.